Literature DB >> 17594939

Synergistic inhibition of pseudorabies virus replication by porcine alpha/beta interferon and gamma interferon in vitro.

Qingxia Yao1, Ping Qian, Yi Cao, Yannan He, Youhui Si, Zhuofei Xu, Huanchun Chen.   

Abstract

Interferon (IFN) is crucial for initiating the innate immune response and for the generation of the adaptive response. IFN, in most species, comprises IFN-alpha (IFN-alpha), IFN-beta (IFN-beta) and IFN-gamma (IFN-gamma). In this study, we compared the capacity of porcine IFN-alpha, -beta and -gamma, or a combination of them, to protect IBRS-2 cells (porcine kidney cells) from infection with pseudorabies virus (PRV). The results demonstrated that porcine IFN-beta (PoIFN-beta) was the most efficient of the three IFNs in conferring resistance PRV infection; 100 U/mL PoIFN-beta inhibited PRV plaque formation 5.3-fold. Compared with PoIFN-beta, porcine IFN-gamma (PoIFN-gamma) was less capable of inhibiting PRV plaque formation (3.3-fold inhibition). Porcine IFN-alpha (PoIFN-alpha) had the least capability of the three PoIFNs, and inhibited PRV plaque formation only 1.26-fold. The inhibitory capacity increased to only 2.3-fold with a treatment of 12,800 U/mL PoIFN-alpha. A combination of PoIFN-gamma and PoIFN-alpha or PoIFN-beta inhibited PRV plaque formation 12.8-fold or 100-fold, respectively. Treatment of IBRS-2 cells with PoIFN-alpha/beta and PoIFN-gamma inhibited PRV replication 29- or 146-fold. Additionally, real-time PCR analyses of the PRV immediate early (IE) gene revealed that IE mRNA expression was profoundly decreased in cells stimulated with PoIFN-alpha/beta and PoIFN-gamma (23.8-133.0-fold) compared with vehicle-treated cells. All the findings indicate that PoIFN-gamma acts synergistically with other PoIFNs (PoIFN-alpha and -beta) to potently inhibit PRV replication in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17594939     DOI: 10.1684/ecn.2007.0088

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  7 in total

1.  Cytokine protein expression levels in tracheobronchial lymph node homogenates of pigs infected with pseudorabies virus.

Authors:  Laura C Miller; Eraldo L Zanella; W Ray Waters; Kelly M Lager
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

2.  Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-beta.

Authors:  Eric Bartee; Grant McFadden
Journal:  Cytokine       Date:  2009-07-28       Impact factor: 3.861

3.  The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts.

Authors:  Eric Bartee; Mohamed R Mohamed; M Cecilia Lopez; Henry V Baker; Grant McFadden
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

4.  Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications.

Authors:  Jialei Sun; Thinesshwary Yogarajah; Regina Ching Hua Lee; Parveen Kaur; Masafumi Inoue; Yong Wah Tan; Justin Jang Hann Chu
Journal:  Sci Rep       Date:  2020-05-18       Impact factor: 4.379

Review 5.  The Swine IFN System in Viral Infections: Major Advances and Translational Prospects.

Authors:  Elisabetta Razzuoli; Federico Armando; Livia De Paolis; Malgorzata Ciurkiewicz; Massimo Amadori
Journal:  Pathogens       Date:  2022-01-27

6.  The Construction and Immunogenicity Analyses of Recombinant Pseudorabies Virus With NADC30-Like Porcine Reproductive and Respiratory Syndrome Virus-Like Particles Co-expression.

Authors:  Jun Zhao; Ling Zhu; Lei Xu; Fengqing Li; Huidan Deng; Yao Huang; Sirui Gu; Xianggang Sun; Yuancheng Zhou; Zhiwen Xu
Journal:  Front Microbiol       Date:  2022-03-02       Impact factor: 5.640

Review 7.  Tumor necrosis factor and interferon: cytokines in harmony.

Authors:  Eric Bartee; Mohamed R Mohamed; Grant McFadden
Journal:  Curr Opin Microbiol       Date:  2008-07-01       Impact factor: 7.934

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.